These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35510655)

  • 21. Efficacy and Safety of Risperidone and Quetiapine in Adolescents With Bipolar II Disorder Comorbid With Conduct Disorder.
    Masi G; Milone A; Stawinoga A; Veltri S; Pisano S
    J Clin Psychopharmacol; 2015 Oct; 35(5):587-90. PubMed ID: 26226481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The case for atypical antipsychotics in bipolar disorder.
    Shattell M; Keltner NL
    Perspect Psychiatr Care; 2004; 40(1):34-8. PubMed ID: 15147051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Did FDA Decisionmaking Affect Anti-Psychotic Drug Prescribing in Children?: A Time-Trend Analysis.
    Wang B; Franklin JM; Eddings W; Landon J; Kesselheim AS
    PLoS One; 2016; 11(3):e0152195. PubMed ID: 27032095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
    McIntyre RS; Mancini DA; Srinivasan J; McCann S; Konarski JZ; Kennedy SH
    Can J Clin Pharmacol; 2004; 11(2):e218-26. PubMed ID: 15520475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative effectiveness of second-generation antipsychotic medications in early-onset schizophrenia.
    Olfson M; Gerhard T; Huang C; Lieberman JA; Bobo WV; Crystal S
    Schizophr Bull; 2012 Jun; 38(4):845-53. PubMed ID: 21307041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medication patterns and costs associated with olanzapine and other atypical antipsychotics in the treatment of bipolar disorder.
    Zhu B; Kulkarni PM; Stensland MD; Ascher-Svanum H
    Curr Med Res Opin; 2007 Nov; 23(11):2805-14. PubMed ID: 17910804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute phase results from STORM, a multicountry observational study of bipolar disorder treatment and outcomes.
    Treuer T; Oruc L; Loza N; El Saidi MA; Kovacs Z; Akkaya C; Gülseren S; Saylan M; Colman SA; Harrison GA
    Psychiatr Danub; 2007 Dec; 19(4):282-95. PubMed ID: 18000479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical antipsychotics: newer options for mania and maintenance therapy.
    Vieta E; Goikolea JM
    Bipolar Disord; 2005; 7 Suppl 4():21-33. PubMed ID: 15948764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes.
    Park Y; Hernandez-Diaz S; Bateman BT; Cohen JM; Desai RJ; Patorno E; Glynn RJ; Cohen LS; Mogun H; Huybrechts KF
    Am J Psychiatry; 2018 Jun; 175(6):564-574. PubMed ID: 29730938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment adherence among patients with bipolar or manic disorder taking atypical and typical antipsychotics.
    Gianfrancesco FD; Rajagopalan K; Sajatovic M; Wang RH
    J Clin Psychiatry; 2006 Feb; 67(2):222-32. PubMed ID: 16566617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis.
    Cipriani A; Barbui C; Salanti G; Rendell J; Brown R; Stockton S; Purgato M; Spineli LM; Goodwin GM; Geddes JR
    Lancet; 2011 Oct; 378(9799):1306-15. PubMed ID: 21851976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimanic response to aripiprazole in bipolar I disorder patients is independent of the agitation level at baseline.
    Sachs GS; Gaulin BD; Gutierrez-Esteinou R; McQuade RD; Pikalov A; Pultz JA; Sanchez R; Marcus RN; Crandall DT
    J Clin Psychiatry; 2007 Sep; 68(9):1377-83. PubMed ID: 17915976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children.
    Biederman J; Mick E; Hammerness P; Harpold T; Aleardi M; Dougherty M; Wozniak J
    Biol Psychiatry; 2005 Oct; 58(7):589-94. PubMed ID: 16239162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risperidone in the treatment of mixed state bipolar patients: results from a 24-week, multicenter, open-label study in Korea.
    Woo YS; Bahk WM; Jon DI; Chung SK; Lee SY; Ahn YM; Pae CU; Cho HS; Kim JG; Hwang TY; Lee HS; Min KJ; Lee KU; Yoon BH
    Psychiatry Clin Neurosci; 2010 Feb; 64(1):28-37. PubMed ID: 19895394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial.
    Perlis RH; Baker RW; Zarate CA; Brown EB; Schuh LM; Jamal HH; Tohen M
    J Clin Psychiatry; 2006 Nov; 67(11):1747-53. PubMed ID: 17196055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Twelve-month prospective, multinational, observational study of factors associated with recovery from mania in bipolar disorder in patients treated with atypical antipsychotics.
    Dikeos D; Badr MG; Yang F; Pesek MB; Fábián Z; Tapia-Paniagua G; Hudiţă C; Okasha T; D'yachkova Y; Harrison G; Treuer T
    World J Biol Psychiatry; 2010 Jun; 11(4):667-76. PubMed ID: 20334575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment.
    Juncal-Ruiz M; Ramirez-Bonilla M; Gomez-Arnau J; Ortiz-Garcia de la Foz V; Suarez-Pinilla P; Martinez-Garcia O; Neergaard KD; Tabares-Seisdedos R; Crespo-Facorro B
    Psychopharmacology (Berl); 2017 Sep; 234(17):2563-2570. PubMed ID: 28567698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.